Search company, investor...

Founded Year



Series A | Alive

Total Raised


Last Raised

$24M | 3 mos ago

About Cradle

Cradle is a company focused on the intersection of biology and artificial intelligence, operating within the biotechnology industry. The company offers a platform that aids biologists in designing improved proteins swiftly, utilizing advanced prediction algorithms and AI design suggestions. Cradle primarily serves the biotechnology sector. It was founded in 2021 and is based in Delft, Netherlands.

Headquarters Location

Alexander Fleminglaan 1

Delft, 2613 AX,



Cradle's Product Videos

ESPs containing Cradle

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Drug R&D Tech

The generative AI — protein & drug design market offers solutions that aim to accelerate and de-risk the drug development process. By using generative AI, companies can significantly reduce the time and cost of drug discovery, expedite the development cycle to design next-generation therapeutics and vaccines, and engineer proteins with fewer experiments. These technologies can increase the accurac…

Cradle named as Leader among 15 other companies, including Insilico Medicine, Exscientia, and Evozyne.

Cradle's Products & Differentiators

    Protein Structure

    (beta) Understanding the structure of a protein


Research containing Cradle

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Cradle in 6 CB Insights research briefs, most recently on Feb 5, 2024.

Expert Collections containing Cradle

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cradle is included in 5 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

11,383 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


AI 100

100 items


Generative AI 50

50 items

CB Insights' list of the 50 most promising private generative AI companies across the globe.


Generative AI

539 items

Companies working on generative AI applications and infrastructure.

Latest Cradle News

New Life Sciences Startup Incubator Launches in Puerto Rico, a Cradle of the Biotech Space

Jan 25, 2024

New Life Sciences Startup Incubator Launches in Puerto Rico, a Cradle of the Biotech Space Puerto Rico is well known for its scenic beaches, lush jungles and friendly and animated people. Lesser known is that Puerto Rico is also a historical powerhouse in the biotech and pharmaceutical industries. The island is the fifth largest area in the world for pharma manufacturing, and large companies like Novartis, Pfizer, Bristol Myers Squibb and others have had operations in Puerto Rico. So it comes as no surprise really that Puerto Rico would be home to a brand new, state of the art incubator for life sciences companies. This week, the Puerto Rico Science Technology and Research Trust (PRSTRT), along with its acceleration program parallel18 , announced the launch of BioLeap, an incubator specialized in assisting life sciences projects to increase economic development through innovation and entrepreneurship. The incubator focuses on key areas such as biotechnology, AI-driven medical technologies, genomics, among many others. “Our mission is to drive visionary projects from the laboratory to the market, accelerating research towards tangible solutions,” said Lucy Crespo, CEO of the PRSTRT. Lucy Crespo, CEO, PRSTRT “In a field where promising ideas often struggle to navigate the complex and lengthy journey from concept to market, BioLeap steps in as a catalyst to transform this process, offering strategic education, resources, and a collaborative ecosystem.” According to a company statement, BioLeap’s curriculum aims to close the gap between innovative local scientific research and its commercialization, while advancing the establishment of a local and inclusive ecosystem. The directors have also announced they’re taking applications for the program from now until February 29. Startups that are accepted into the program will receive 12 weeks of education and mentoring aimed at teaching participants about entrepreneurship and the intricacies of doing business within the life sciences industry. Additionally, the incubation program will include an additional 14-week period of technical assistance once each cohort ends. During this time, the alumni will continue to receive mentoring and guidance in the various aspects of their business, including finance, operations, grant writing, marketing and communications, as well as assistance in research and development, corporate connections, access to capital and more. BioLeap, via parallel18, also provides founders with access to capital, a co-working space for the team, and other technical assistance. Founders will also be connected with parallel18’s wider network of startup founders and investors. “We want to empower researchers and entrepreneurs to take their innovative technologies to another level,” said Crespo.

Cradle Frequently Asked Questions (FAQ)

  • When was Cradle founded?

    Cradle was founded in 2021.

  • Where is Cradle's headquarters?

    Cradle's headquarters is located at Alexander Fleminglaan 1, Delft.

  • What is Cradle's latest funding round?

    Cradle's latest funding round is Series A.

  • How much did Cradle raise?

    Cradle raised a total of $29.7M.

  • Who are the investors of Cradle?

    Investors of Cradle include Index Ventures, Kindred Capital, Tom Glocer, Chris Gibson, Emily Leproust and 4 more.

  • Who are Cradle's competitors?

    Competitors of Cradle include Aqemia, Arzeda, Valence, InstaDeep, Insilico Medicine and 7 more.

  • What products does Cradle offer?

    Cradle's products include Protein Structure and 4 more.


Compare Cradle to Competitors

InstaDeep Logo

InstaDeep develops artificial intelligence-enabled decision-making systems for enterprises. It provides predictive analytics solutions for enterprise clients, particularly in the biomedical, mobility, and transportation spaces and offers and its product line includes DeepChain, DeepPack, and DeepPCB. InstaDeep was formerly known as Digital Ink Group. It was founded in 2014 and is based in London, United Kingdom. In January 2023, InstaDeep was acquired by BioNTech.

Aqemia Logo

Aqemia serves as a pharma tech company that focuses on transforming the drug discovery process. Its main service is leveraging technology that combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a rapidly growing pipeline of new drug candidates. It primarily sells to the pharmaceutical industry. It was founded in 2019 and is based in Paris, France.

Insilico Medicine Logo
Insilico Medicine

Insilico Medicine operates as a clinical-stage biotechnology company operating in pharmaceutical research and development. It offers services such as novel target discovery, generation of molecular structures with desired properties, and clinical trial analysis. Its services primarily cater to the healthcare industry, with a particular emphasis on the discovery and development of innovative drugs for a range of conditions including cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. It was founded in 2014 and is based in New Territories, Hong Kong.

Biomatter Designs Logo
Biomatter Designs

Biomatter Designs is a company focused on the engineering of proteins, operating within the health and sustainable manufacturing sectors. The company's main service involves the creation and design of proteins for use in health applications and sustainable manufacturing processes. It was founded in 2018 and is based in Vilnius, Lithuania.

Variational AI Logo
Variational AI

Variational AI is a healthcare company. The company uses artificial intelligence to develop new small-molecule drugs. It was founded in 2019 and is based in Vancouver, Canada.

YDS Pharmatech

YDS Pharmatech is a company focused on drug discovery in the pharmaceutical industry. The company offers a platform for the design of new drug candidates, utilizing structure-based de novo drug design and evolutionary AI to accelerate the drug discovery process. YDS Pharmatech primarily serves the pharmaceutical industry. It was founded in 2020 and is based in Albany, New York.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.